Scandinavian Biolabs ApS — Credit Rating and Financial Key Figures
CVR number: 41170514
Lindgreens Allé 9, 2300 København S
accounts@scandinavianbiolabs.com
tel: 70605708
https://scandinavianbiolabs.com/
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | -1 145.35 | -1 883.46 | 1 591.10 | 5 145.09 |
| Employee benefit expenses | - 629.90 | -2 691.86 | -4 006.26 | -5 978.97 |
| Total depreciation | -4.65 | -13.93 | ||
| EBIT | -1 779.90 | -4 589.25 | -2 415.15 | - 833.89 |
| Other financial income | 0.09 | 3.22 | 88.49 | 16.49 |
| Other financial expenses | -1.49 | -26.09 | - 189.16 | - 536.16 |
| Pre-tax profit | -1 781.31 | -4 612.12 | -2 515.83 | -1 353.56 |
| Net earnings | -1 781.31 | -4 612.12 | -2 515.83 | -1 353.56 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Machinery and equipment | 13.93 | |||
| Tangible assets total | 13.93 | |||
| Other receivables | 50.00 | 50.00 | 50.00 | |
| Investments total | 50.00 | 50.00 | 50.00 | |
| Long term receivables total | ||||
| Semifinished products | 633.71 | 705.57 | 587.51 | |
| Finished products/goods | 260.98 | 824.41 | 1 274.74 | 3 884.20 |
| Inventories total | 260.98 | 1 458.12 | 1 980.31 | 4 471.70 |
| Current trade debtors | 116.45 | 604.28 | 1 239.06 | 2 612.24 |
| Prepayments and accrued income | 288.05 | 86.21 | 241.66 | |
| Current other receivables | 112.25 | 89.61 | ||
| Short term receivables total | 116.45 | 892.33 | 1 437.51 | 2 943.51 |
| Cash and bank deposits | 87.22 | 144.10 | 223.84 | 3 883.12 |
| Cash and cash equivalents | 87.22 | 144.10 | 223.84 | 3 883.12 |
| Balance sheet total (assets) | 478.57 | 2 544.54 | 3 691.66 | 11 348.33 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 2 933.33 | 2 933.33 | 3 141.35 |
| Retained earnings | -1 735.75 | -6 347.87 | -3 071.72 | |
| Profit of the financial year | -1 781.31 | -4 612.12 | -2 515.83 | -1 353.56 |
| Shareholders equity total | -1 741.31 | -3 414.54 | -5 930.37 | -1 283.92 |
| Non-current liabilities total | ||||
| Current loans from credit institutions | 1 091.15 | 1 268.47 | ||
| Current trade creditors | 2 519.03 | 3 889.35 | 5 869.54 | |
| Current owed to group member | 1 500.00 | 559.32 | 3 661.76 | 4 371.26 |
| Other non-interest bearing current liabilities | 719.88 | 1 789.58 | 350.21 | 1 287.66 |
| Accruals and deferred income | 452.24 | 1 103.79 | ||
| Current liabilities total | 2 219.88 | 5 959.08 | 9 622.03 | 12 632.25 |
| Balance sheet total (liabilities) | 478.57 | 2 544.54 | 3 691.66 | 11 348.33 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.